Nephrology · Flint, MI
NPI
1467442038
Since 2005
Specialty
Nephrology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2486 Nerredia St, Suite E
Flint, MI, 48532
Phone (810) 230-9901
Groups this clinician bills Medicare through
Medicare paid, 2024
$189K
1,933 services
Medicare patients, 2024
557
Average age 72
Drug cost, 2024
$1.5M
4,370 prescriptions
Company payments, 2025
$925
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sayed Osama was code 99232 (hospital e&m - subsequent), 628 times for 192 patients. In total Sayed Osama billed 1,933 services in 18 codes, and Medicare paid $189K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 628 | 192 | $59.91 | $38K |
| 99214 Office E&M - Established | Office | 290 | 200 | $74.65 | $22K |
| 90960 ESRD Related Services (not dialysis) | Office | 176 | 30 | $270.20 | $48K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 169 | 133 | $12.48 | $2,108 |
| 99213 Office E&M - Established | Office | 157 | 141 | $51.18 | $8,036 |
| 90966 ESRD Related Services (not dialysis) | Office | 137 | 19 | $227.83 | $31K |
| 90935 Hemodialysis | Facility | 91 | 45 | $53.77 | $4,893 |
| 99223 Hospital E&M - Initial | Facility | 73 | 69 | $131.55 | $9,603 |
| 99222 Hospital E&M - Initial | Facility | 68 | 50 | $99.50 | $6,766 |
| 99233 Hospital E&M - Subsequent | Facility | 39 | 27 | $90.15 | $3,516 |
| 90961 ESRD Related Services (not dialysis) | Office | 36 | 18 | $227.49 | $8,189 |
| 99204 Office E&M - New | Office | 21 | 21 | $121.53 | $2,552 |
By year: 2022 $330K for 2,819 services; 2023 $270K for 2,460 services; 2024 $189K for 1,933 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sayed Osama prescribed most often to Medicare patients was Amlodipine Besylate, with 264 prescriptions and refills. In total Sayed Osama wrote 4,370 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 264 | 628 | 107 | $1,957 |
| Jardiance Empagliflozin | 224 | 446 | 97 | $253K |
| Losartan Potassium Generic | 188 | 484 | 83 | $1,834 |
| Bumetanide Generic | 152 | 293 | 56 | $4,638 |
| Ozempic Semaglutide | 138 | 212 | 43 | $186K |
| Mounjaro Tirzepatide | 127 | 179 | 48 | $187K |
| Carvedilol Generic | 122 | 268 | 42 | $1,078 |
| Potassium Chloride Generic | 118 | 246 | 47 | $2,093 |
| Calcitriol Generic | 114 | 258 | 42 | $2,235 |
| Hydralazine Hcl Generic | 113 | 267 | 46 | $1,793 |
| Nifedipine Er Nifedipine | 107 | 260 | 44 | $4,248 |
| Lisinopril Generic | 106 | 282 | 48 | $647 |
| Sevelamer Carbonate Generic | 102 | 164 | 39 | $18K |
| Doxazosin Mesylate Generic | 96 | 222 | 38 | $1,883 |
| Calcium Acetate Generic | 93 | 193 | 37 | $8,343 |
Brand drugs: 1,083 claims; generic drugs: 3,267 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sayed Osama $925 ($925 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $138.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $138 |
| Scpharmaceuticals Inc. SCPH | 5 | $103 |
| Travere Therapeutics, Inc. TVTX | 4 | $85.5 |
| Amgen Inc. AMGN | 4 | $80.29 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $76.31 |
| Calliditas Therapeutics US Inc. | 4 | $69.27 |
| Recor Medical Inc | 3 | $58.79 |
| Akebia Therapeutics Inc AKBA | 2 | $46.9 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $46.76 |
| Novo Nordisk Inc NVO | 2 | $42.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.